(Q34942667)

5 August 2017

1 reference

title

Combined modality treatments in early non-small cell lung cancer (English)

1 reference

5 August 2017

Peter Harper

1

1 reference

5 August 2017

Gavin M Marx

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

38

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

S23-5

1 reference

5 August 2017

cites work

Cancer statistics, 1988

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

Randomized trial of neoadjuvant therapy for lung cancer: interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

Age and the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900248-9

7 January 2021

10.1016/S0169-5002(02)00248-9

Identifiers

DOI

1 reference

5 August 2017

1 reference